Dataset: cfc_mdi.csv

Source: L.I. Harrison, I. Soria, A.C. Cline, B.P. Ekholm (1999). "Pharmacokinetic Differences
Between Chlorofluorocarbon and Chlorofluorocarbon-free Metered Dose Inhalers of
Beclomethasone Dipropianote in Adult Asthmatics," Journal of Pharmacy and Pharmacology,
Vol. 51, Issue 11, pp. 1235-1240.

Description:
Comparison of 3 formulations beclomethasone diproprianote in a 3-period crossover design.
Formulations: 
1 = 200 mu g HFA (hydrofluoroalkane HFA-134a)
2 = 400 mu g  "            "          "   "
3 = 400 mu g CFC (chlorofluorocarbon)
Study had 23 subjects complete and no information on periods/sequences/carryover
Responses: Maximum concentration, Area Under Curve, Time to Max for Beclamethasone and its esters

Variable Names:
subject   (1-13,15-24)
formulation  (1 = 200 mu g HFA, 2 = 400 mu g HFA, 3 = 400 mu g CFC)
Cmax_Be     (Maximum concentration of beclamethasone esters, pg/mL)
AUC_Be      (Area Under Concentration Time Curve of beclamethasone esters, pg h / mL)
Tmax_Be     (Time to Maximum concentration of beclamethasone esters, h)
Cmax_B     (Maximum concentration of beclamethasone, pg/mL)
AUC_B      (Area Under Concentration Time Curve of beclamethasone, pg h / mL)
Tmax_B     (Time to Maximum concentration of beclamethasone, h)